Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
Sponsor: M.D. Anderson Cancer Center
A observational or N/A phase clinical study on Cancer and HBV, this trial is completed. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 14 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2022 — Sep 2022 [monthly]
Active Not Recruiting
-
Dec 2021 — Mar 2022 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
May 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jan 2018 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .